Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model
The potential of inhibitory metabolites of perpetrator drugs to contribute to drug-drug interactions (DDIs) is uncommon and underestimated. However, the occurrence of unexpected DDI suggests the potential contribution of metabolites to the observed DDI. The aim of this study was to develop a physiol...
Main Authors: | Caifu Xue, Xunjie Zhang, Weimin Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/10/1/1 |
Similar Items
-
Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network
by: Fatima Zahra Marok, et al.
Published: (2021-03-01) -
Stereoselective disposition of bupropion and its three major metabolites : 4-hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion
by: Masters, Andrea Renee
Published: (2016) -
Methaemoglobinemia Induced by Poppers and Bupropion Intoxication in the Emergency Department
by: Frederico Batista, et al.
Published: (2019-03-01) -
Bupropion-associated movement disorders: A systematic review
by: Jamir Pitton Rissardo, et al.
Published: (2020-01-01) -
Is psychosexual therapy a reliable alternative to bupropion extended-release to promote the sexual function in infertile women? An RCT
by: Hajar Pasha, et al.
Published: (2020-03-01)